(Q34384590)

English

A critical review of the probable reasons for the poor variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

A critical review of the probable reasons for the poor variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

based on heuristic

inferred from title

bioavailability

1 reference

based on heuristic

inferred from title

author name string

Singh S

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Mariappan TT

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Shankar R

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sarda N

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Singh B

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

International Journal of Pharmaceutics

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

228

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

5-17

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900754-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of the inhibitory effect of PAS granules on the absorption of rifampicin: Adsorption of rifampicin by an excipient, bentonite

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900754-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetic studies of the interaction between isoniazid and reducing sugars

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900754-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900754-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Solubility and dissolution properties of generic rifampicin raw materials

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900754-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The promise and reality of fixed-dose combinations with rifampicin. A joint statement of the International Union Against Tuberculosis and Lung Disease and the Tuberculosis Programme of the World Health Organization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900754-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Absorption of rifampin from various preparations and pharmaceutic forms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900754-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Stability of isoniazid, rifampin and pyrazinamide in suspensions used for the treatment of tuberculosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900754-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Stability of rifampicin in dissolution medium in presence of isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900754-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hydrolysis of temazepam in simulated gastric fluid and its pharmacological consequence

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900754-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0378-5173(01)00754-2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34384590&oldid=2042189427"